Pre-Open Movers 7/31: Imclone (IMCL) Surges On Takeover Offer; Akamai (AKAM) Sinks On Results/Guidance

July 31, 2008 9:27 AM EDT

StreetInsider.com Pre-Open Movers:

Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) 55% HIGHER received written guidance from the FDA that one post-operative pain trial (Sinatra Study) and one fever trial (Study 302) are sufficient to meet the pivotal clinical trial requirements for submission of a New Drug Application (NDA) for Acetavance, the company's intravenous formulation of acetaminophen for the treatment of acute pain and fever in adults and children

Imclone Systems Inc. (Nasdaq: IMCL) 40% HIGHER; Bristol -Myers Squibb (NYSE: BMY) offers to acquire the company for $60 per share.

Bare Escentuals (Nasdaq: BARE) 22% LOWER; reports Q2 results; guides lower

Akamai Technologies Inc. (Nasdaq: AKAM) 17% LOWER; reports Q2 EPS of $0.41, versus the analyst estimate of $0.41. Revenues for the quarter were $194 million, versus the consensus of $196.72 million. Akamai sees Q3 EPS of $0.39-$0.40, versus the consensus of $0.41. Sees '08 EPS of $1.63-$1.69, versus the consensus of $1.70.

Hologic (Nasdaq: HOLX) 17% LOWER; reports Q3 EPS of $0.33, 4 cents better than the analyst estimate of $0.29. Revenues for the quarter were $429.5 million, versus the consensus of $435.80 million. Sees Q4 sales in the range of $438-$439 million, versus the consensus of $452.56 million. FY08 sales are expected to be about $1.67 billion, versus the consensus of $1.69 billion. EPS for the year move from $1.15-$1.18 to about $1.18, versus $1.15.

PharmaNet Development Group, Inc. (Nasdaq: PDGI) 16% HIGHER; reports Q2 earnings of $0.11 per share, below the consensus of $0.30. Revenues came in at $96.8 million, versus the consensus of $103.7 milion. Sees FY08 EPS of $0.53-$0.63 versus the consensus of $0.16. Sees FY revs of $390-$399 million, versus the consensus of $385.72 million.

Calgon Carbon Corp. (NYSE: CCC) 15% HIGHER; reports Q2 EPS of $0.25, 13 cents better than the analyst estimate of $0.12. Revenues for the quarter were $109 million, versus the consensus of $97 million.

ARRIS Group, Inc. (Nasdaq: ARRS) 14% HIGHER; reports Q2 EPS of $0.15, 1 cents better than the analyst estimate of $0.14. Revenues for the quarter were $281.1 million, versus the consensus of $281.69 million. Sees Q3 EPS of $0.19-$0.24, versus the consensus of $0.18 and revs of $288-$308 million, versus the consensus of $304.6 million.

Motorola (NYSE: MOT) 12% HIGHER; reports Q2 earnings of $0.02 per share, ex-items, above the consensus of $0.03 loss. Revenues came in at $8.08 billion, versus the consensus of $7.69 billion. Sees Q3 EPS of $0.00-$0.02, ex-items, versus the consensus of $0.01. Sees FY08 sees EPS of $0.06-$0.08, ex-items, versus the consensus of $0.01.

Tetra Tech (Nasdaq: TTEK) 11% HIGHER; reports Q3 EPS of $0.27, 3 cents better than the analyst estimate of $0.24. Revenues for the quarter were $332.3, versus the consensus of $304.33 million. Tetra Tech sees Q4 eps 27-29 cents versus 26 cents.

THQ Inc (Nasdaq: THQI) 10.6% LOWER; reports a Q1 loss of $0.38, versus the analyst estimate of ($0.38). Revenues for the quarter were $137.6 million, versus the consensus of $121.12 million. THQ sees Q2 loss of 35-39 cents versus 12 cents consensus. Sees Q2 sales $160-$170 million versus $230 million. THQ sees FY09 EPS 80-90 cents versus 99 cents. Sees FY09 revenue $1.15-$1.75 billion versus consensus of $1.18 billion.

Andersons, Inc. (Nasdaq: ANDE) 9.4% HIGHER; expects its full-year earnings per share to exceed previous guidance. The full-year 2008 guidance is expected to be within the range of $5.00 and $5.40 per diluted share, up from the previous estimate of $4.40 to $4.80 per diluted share announced in June. The Wall Street consensus is $4.61.

Gentiva Health (Nasdaq: GTIV) 6% HIGHER; Reports Q2 earnings of $0.41 per share, above the consensus of $0.32. Revenues came in at $346.2 million, versus the consensus of $329.1 million. Sees FY08, EPS of $1.36-$1.43, ex-items, versus previous guidance of $1.32-$1.40 and the consensus of $1.32.

Tyco (NYSE: TYC) 6% HIGHER; reports Q3 earnings of $0.88 per share, ex-items, above the consensus of $0.67. Revenues came in at $5.21 billion, versus the consensus of $5.15 billion. Sees FY08 EPS of $2.97-$2.99 versus the consensus of $2.76.

First Solar, Inc. (Nasdaq: FSLR) 6% HIGHER; reports Q2 EPS of $0.85, versus the analyst estimate of $0.58. Revenues for the quarter were $267 million, versus the consensus of $216.90 million.

Digital River, Inc. (Nasdaq: DRIV) 6% HIGHER; reports Q3 EPS of $0.37, 4 cents better than the analyst estimate of $0.33. Revenues for the quarter were $98.4 million, versus the consensus of $91.02 million. Sees FY08 EPS of $2.00, versus the consensus of $1.90 and sales of $410 million, versus $401 million.

Trinity Industries (NYSE: TRN) 6% HIGHER; reports Q2 EPS of $0.98, 12 cents better than the analyst estimate of $0.86. Revenues for the quarter were $945.5 million, versus the consensus of $957.63 million. Sees Q3 EPS of $0.91-$0.96, versus the consensus of $0.81.

Atmel Corporation (Nasdaq: ATML) 5.8% HIGHER; reports Q2 EPS of $0.04, 3 cents better than the analyst estimate of $0.01. Revenues for the quarter were $420.9 million, versus the consensus of $419.33 million. Sees Q3 revs down 3-7% sequentially, excluding a charge, would be up 1-4%, sequentially.

Schering-Plough Corp. (NYSE: SGP) 5% HIGHER; Merrill upgrades to Buy

Amylin Pharmaceuticals Inc. (Nasdaq: AMLN) 5% HIGHER; Sees a boost after Bristol-Myers offered to buy ImClone for $60 per share. Carl Icahn is a shareholder of AMLN and IMCL.

MasterCard Incorporated (NYSE: MA) 5% LOWER; reports Q2 EPS of $2.11, 9 cents better than the analyst estimate of $2.02. Revenues for the quarter were $1.2 billion, versus the consensus of $1.21 billion.

Itron, Inc. (Nasdaq: ITRI) 5% HIGHER; reports Q2 EPS of $1.02, 20 cents better than the analyst estimate of $0.82. Revenues for the quarter were $514 million, versus the consensus of $476.38 million. Itron raises guidance.

The Goodyear Tire & Rubber Company (NYSE: GT) 4% HIGHER; reports Q2 EPS of $0.67, ex-items, 7 cents better than the analyst estimate of $0.60. Revenues for the quarter were $5.2 billion, versus the consensus of $5.26 billion.

Las Vegas Sands (NYSE: LVS) 3.8% LOWER; reports Q2 EPS of $0.09, 2 cents lower than the analyst estimate of $0.11. Revenues for the quarter were $1.11 billion, versus the consensus of $1.11 billion.

Starbucks (Nasdaq: SBUX) 3.7% HIGHER; reports Q2 EPS of $0.16, 2 cents below the analyst estimate of $0.18. Revenues for the quarter were $2.57 billion, versus the consensus of $2.61 billion. Sees FY08 revenue growth of 11%.

General Maritime Corporation (NYSE: GMR) 3.6% HIGHER; reports Q2 EPS of $0.67, 12 cents better than the analyst estimate of $0.55. Revenues for the quarter were $80.9 million, versus the consensus of $64.40 million

Priceline.com Inc. (NASDAQ: PCLN) 3.4% HIGHER; will replace KEMET Corp. (NYSE: KEM) in the S&P MidCap 400 after the close of trading on Friday, August 1. As of today’s close of trading KEMET had a market capitalization of approximately $144 million, ranking 400th in the index.

Express Scripts, Inc. (Nasdaq: ESRX) 3% HIGHER; reports Q2 EPS of $0.76, 4 cents better than the analyst estimate of $0.72. Revenues for the quarter were $4.7 billion, versus the consensus of $4.75 billion. Sees FY08 EPS of $3.03-$3.10, versus the consensus of $3.00.

Walt Disney (NYSE: DIS) 2.3% LOWER; reports Q3 EPS of $0.62, ex-items, 1 cent better than the analyst estimate of $0.61. Revenues for the quarter were $9.24 billion, versus the consensus of $9.14 billion.

Exxon Mobil Corp. (NYXE: XOM) 2% LOWER; reports Q2 EPS of $2.27, ex-items, versus the consensus of $2.52. Q2 revenues were $138.07 billion, versus the consensus of $144.4 billion.

Kansas City Southern (NYSE: KSU) 2% LOWER; reports Q2 earnings of $0.56 per share, 12 cents above the consensus of $0.44. Revenues came in at $486.2 million, versus the consensus of $465.64 million.

Visa Inc. (NYSE: V) 2% LOWER; reports Q2 EPS of $0.59, 11 cents better than the analyst estimate of $0.48. Revenues for the quarter were $1.6 billion, versus the consensus of $1.55 billion.

Brinks (NYSE: BCO) INDICATED HIGHER; reports Q2 earnings of $1.04 per share, above the consensus of $0.77. Revenues came in at $932 million, versus the consensus of $875.7 million.

Get This Report E-Mailed To You Daily and Much, Much More With StreetInsider.com Premium - FREE TRIAL

Related Categories

Special Reports

Stocks Mentioned

Related Entities

• Carl Icahn

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?